Zogenix is a growing U.S.-based pharmaceutical company passionate about taking on the complex challenges of developing therapeutic solutions with the potential to transform the lives of rare disease patients and their families.

To learn more about the company’s current development projects, www.zogenix.com.


Our Representatives

Gail Farfel

Chief Development Officer, Zogenix

Chief Development Officer

Zogenix

Zogenix is committed to developing and commercializing therapies with the potential to transform the lives of patients and their families living with rare diseases.